Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Georgia Fogden-King's Articles

Exosome Isolation Manufacturing & Characterization

AMSBIO has announced an exosome isolation, manufacturing and characterization service to enable R&D groups to accelerate their discovery and development activities.

Powerful CRISPR/Cas9 Gene Editing Kits

AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications.

AMSBIO Launch New Screening Company

ScreenIn3D (Glasgow, UK) is a new joint venture company set up by AMSBIO and the University of Strathclyde exploiting the latest advances in microfluidics and 3D culture to develop a novel microfluidic screening platform.

Adaptix Imaging is winner of The Oxford Science Park Innovation Award 2018

New 3D approach to X-ray imaging recognised as part of Oxfordshire Business Awards

3D-iPSC Matrix Enables More Accurate In Vivo Predictions

AMSBIO announces MyEZGel™ 3D-iPSC Matrix - a powerful new tool for in vitro 3D human induced pluripotent stem cell (hiPSC) culture, enabling more accurate in vivo predictions in life science research and development.

£2.5bn British Patient Capital Programme launched to enable long-term investment in innovative companies across the UK

The British Business Bank is launching British Patient Capital, a new £2.5bn programme designed to enable long-term investment in high growth potential companies across the UK led by ambitious entrepreneurs who want to build successful, world-class businesses.

Cell Culture Medium for Clinical Research

AMSBIO announces the launch of StemFit® Basic03 clinical grade stem cell culture for regenerative medicine

Get up to £200K to accelerate your life sciences startup

Twice a year we invest up to* £200,000 in startups solving global challenges with life itself.

Aurelia Bioscience 

Aurelia Bioscience is a contract research organisation (CRO) specialising in bioassay development and compound screening.

Ground-breaking medical blood treatment passes £1.75 million in funding

MediSieve Ltd, the team behind an innovative blood filtration device, are happy to announce the company has received over £1.75 million in funding.

Pages: Previous1234567...15NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.